home
About Us
About Us
what we do
Tikun Olam Israel
Our Brands
Our Partners
Investors
contact us
Menu
home
About Us
About Us
what we do
Tikun Olam Israel
Our Brands
Our Partners
Investors
contact us
Investor lobby
Company Profile
Accessibility
Financial Reports
Immediate Reports
Presentations & Conference Calls
Events
Investors News
Media
Stock Chart
עברית
Menu
Investor lobby
Company Profile
Accessibility
Financial Reports
Immediate Reports
Presentations & Conference Calls
Events
Investors News
Media
Stock Chart
עברית
investors news
31.08.2022
Tikkun Olam-Cannbit publishes the first midterm financial reports for 2022: The company presents a positive EBITDA with an increase in revenues and a reduction in expenses
read more
29.08.2022
Tikun Olam - Cannbit continues to implement the strategy of penetrating the global arena An exclusive agreement for the production and export of 'Avidekel' oil, a strain rich in CBD which is researched over the world, to the UK
read more
22.08.2022
Tikkun Olam - Cannabit will start exporting its products to Europe already in the forthcoming quarter, after obtaining from the German Ministry of Health the European Union’s GMP-EU standard for the production, export, trade and marketing of cannabis products to Europe The pharmaceutical factory for medical cannabis in accordance with the European GMP-EU standard was established in Israel
read more
17.08.2022
Tikun Olam - Cannbit raised 18.3 million NIS in a rights issue from stakeholders, institutional investors and the company's management The proceeds of the offering are intended for the further implementation of the strategy outlined by the company and global expansion The rights issue was also attended by institutional investors, the senior management of the company, and a number of directors
read more
Facebook
Youtube
Linkedin
home
About Us
About Us
what we do
Tikun Olam Israel
Our Brands
Our Partners
Investors
contact us
Menu
home
About Us
About Us
what we do
Tikun Olam Israel
Our Brands
Our Partners
Investors
contact us